1. Home
  2. AMRO vs HUMA Comparison

AMRO vs HUMA Comparison

Compare AMRO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AMRO

Amaero Inc. Common Stock

N/A

Current Price

$6.33

Market Cap

166.1M

Sector

Industrials

ML Signal

N/A

Logo Humacyte Inc.

HUMA

Humacyte Inc.

N/A

Current Price

$0.45

Market Cap

165.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRO
HUMA
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.1M
165.7M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
AMRO
HUMA
Price
$6.33
$0.45
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $1.63
AVG Volume (30 Days)
453.9K
★ 5.7M
Earning Date
11-09-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.37
EPS
★ N/A
N/A
Revenue
N/A
★ $2,038,000.00
Revenue This Year
$374.17
$72.32
Revenue Next Year
$81.38
$518.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.99
$0.34
52 Week High
$8.64
$1.53

Technical Indicators

Market Signals
Indicator
AMRO
HUMA
Relative Strength Index (RSI) 63.57 50.41
Support Level $5.13 $0.36
Resistance Level $6.60 $0.48
Average True Range (ATR) 0.77 0.05
MACD 0.02 0.01
Stochastic Oscillator 88.51 54.56

Price Performance

Historical Comparison
AMRO
HUMA

About AMRO Amaero Inc. Common Stock

Amaero Inc specializes in manufacturing high-performance powders and near-net-shape components using additive manufacturing and HIP technologies, ensuring precision, material integrity, and reduced times for critical applications. It serves in industries of Aerospace, Defense, Energy, Oil & Gas, and Others. The group leverages cutting-edge gas atomization and hot isostatic pressing (HIP) technologies to create high-performance components that reduce porosity and improve material integrity. Its focus is on reshoring critical materials production and defense manufacturing, offering high-value refractory, specialty, and titanium alloyed powders.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: